MetLife (MET) director Laura J. Hay granted 721 deferred shares as board fees

Rhea-AI Filing Summary

Hay Laura J reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Laura J. Hay received a grant of 721 shares of common stock valued at $71.17 per share as part of non-management director compensation. After this award on April 1, 2026, she directly holds 5,692 shares. The footnote explains that MetLife pays a portion of non-management director retainer fees in common stock, and Hay elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This is a routine, compensation-related share award rather than an open-market purchase.

Insights

Corporate governance analyst

Routine stock-based fee payment to MetLife director, not a market trade.

Laura J. Hay, a non-management director of MetLife Inc., received 721 shares of common stock on April 1, 2026 as part of standard director compensation. The filing labels this as a grant or award acquisition at $71.17 per share.

The footnote clarifies these shares represent a portion of retainer fees paid in stock, with Hay electing to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. This is a compensation mechanism, not an open-market buy, and she now directly holds 5,692 shares.

Because the transaction is small in scale and routine for board compensation, it does not materially change the investment thesis. It primarily illustrates MetLife’s use of equity-based fees to align non-management directors with shareholder interests.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hay Laura J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$71.17	$51K

Holdings After Transaction: Common Stock — 5,692 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Director stock grant: 721 shares Grant value per share: $71.17 per share Director holdings after grant: 5,692 shares

3 metrics

Director stock grant 721 shares Common stock grant on April 1, 2026

Grant value per share $71.17 per share Reported value for April 1, 2026 grant

Director holdings after grant 5,692 shares Total MetLife common stock directly held after transaction

Key Terms

non-management director compensation arrangements, retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors, grant, award, or other acquisition

4 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion"

retainer fees financial

"pay a portion of non-management director retainer fees in MetLife, Inc."

MetLife Deferred Compensation Plan for Non-Management Directors financial

"under the MetLife Deferred Compensation Plan for Non-Management Directors."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hay Laura J

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$71.17	5,692	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MetLife (MET) director Laura J. Hay report in this Form 4?

Laura J. Hay reported receiving 721 shares of MetLife common stock as a grant on April 1, 2026. The shares represent a portion of her non-management director retainer fees paid in stock, rather than an open-market purchase of additional shares.

Was the Laura J. Hay transaction in MetLife (MET) stock a purchase or a grant?

The transaction was a grant or award acquisition, not a market purchase. Code "A" on the Form 4 and the footnote show it reflects stock paid as part of MetLife’s non-management director compensation arrangements, tied to retainer fees.

How many MetLife (MET) shares does Laura J. Hay hold after this Form 4 transaction?

After the April 1, 2026 grant, Laura J. Hay directly holds 5,692 shares of MetLife common stock. This total includes the 721-share award reported, indicating a modest ownership position built partly through stock-based director compensation.

What price per share is associated with Laura J. Hay’s MetLife (MET) stock grant?

The Form 4 lists a value of $71.17 per share for the 721-share grant. This figure is used for reporting the compensation value of the award and does not indicate that Hay executed an open-market trade at that price.

How does MetLife (MET) compensate non-management directors like Laura J. Hay?

MetLife pays a portion of non-management director retainer fees in MetLife common stock. In this case, 721 shares were granted and Hay elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors, aligning compensation with long-term equity.

Did Laura J. Hay defer her MetLife (MET) director share award reported on this Form 4?

Yes. The footnote states she elected to defer receipt of the 721 shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the stock-based retainer fees are credited but delivery is postponed according to plan terms.